BioMarin Pharmaceutical Inc. will pay a premium of approximately $840 million to buy Prosena Holding N.V. (Nasdaq: RNA) sending the stock price leaping $7.16 to close at $18.60.
Prosena to be acquired
November 24, 2014 at 15:55 PM EST
Prosena to be acquiredNovember 24, 2014 at 15:55 PM EST
BioMarin Pharmaceutical Inc. will pay a premium of approximately $840 million to buy Prosena Holding N.V. (Nasdaq: RNA) sending the stock price leaping $7.16 to close at $18.60.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|